Entering text into the input field will update the search result below

Premarket analyst action - healthcare

  • Masimo (NASDAQ:MASI) initiated with Buy rating and $139 (14% upside) price target at Needham citing upside from Philips partnership and its pulse oximeter.
  • Rhythm Pharmaceuticals (NASDAQ:RYTM) initiated with Hold rating and $36 (15% upside) price target at Stifel.
  • Zogenix (NASDAQ:ZGNX) initiated with Buy rating and $63 (29% upside) price target at BofA/Merrill Lynch. Share up 1% premarket.
  • Bovie Medical (NYSEMKT:BVX) initiated with Buy rating and $11 (70% upside) price target at Dougherty & Co.
  • UroGen (NASDAQ:URGN) resumed with Buy rating and $70 (57% upside) price target at Stifel.
  • Sarepta Therapeutics (NASDAQ:SRPT) resumed with Buy rating and $199 (32% upside) price target at BofA/Merrill Lynch. Shares up 1% premarket.
  • Tandem Diabetes Care (NASDAQ:TNDM) downgraded to Neutral at Robert W. Baird. Shares down 4% premarket.

Recommended For You

About MASI Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MASI--
Masimo Corporation